Portal de Periódicos da CAPES

Comments on "cardiotonic activity of amrinone-win 40680 [5-amino-3-4'-bypyridin-6(1H)-one]".

1980; Lippincott Williams & Wilkins; Volume: 46; Issue: 6 Linguagem: Inglês

10.1161/01.res.46.6.887

1524-4571

A M Katz, David McCall, Frank C. Messineo, A Pappano, Ward C. Dobbs,

Trypanosoma species research and implications

HomeCirculation ResearchVol. 46, No. 6Comments on "cardiotonic activity of amrinone-win 40680 [5-amino-3-4'-bypyridin-6(1H)-one]". Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBComments on "cardiotonic activity of amrinone-win 40680 [5-amino-3-4'-bypyridin-6(1H)-one]". A M Katz, D McCall, F C Messineo, A Pappano and W Dobbs A M KatzA M Katz , D McCallD McCall , F C MessineoF C Messineo , A PappanoA Pappano and W DobbsW Dobbs Originally published1 Jun 1980https://doi.org/10.1161/01.RES.46.6.887Circulation Research. 1980;46:887–888"Comments on "cardiotonic activity of amrinone-win 40680 [5-amino-3-4'-bypyridin-6(1H)-one]".." Circulation Research, 46(6), pp. 887–888 Previous Back to top Next FiguresReferencesRelatedDetailsCited ByEndoh M (2013) Amrinone, Forerunner of Novel Cardiotonic Agents, Caused Paradigm Shift of Heart Failure Pharmacotherapy, Circulation Research, 113:4, (358-361), Online publication date: 2-Aug-2013. Hidaka H and Kimura Y (1996) Role of Phosphodiesterase III in the Control of Blood Flow Molecular and Cellular Mechanisms of Cardiovascular Regulation, 10.1007/978-4-431-65952-5_13, (169-181), . Chang A, Atz A, Wernovsky G, Burke R and Wessel D (1995) Milrinone, Critical Care Medicine, 10.1097/00003246-199511000-00018, 23:11, (1907-1914), Online publication date: 1-Nov-1995. Lynn A, Sorensen G, Williams G, Anderson G and Opheim K (1993) Hemodynamic effects of amrinone and colloid administration in children following cardiac surgery, Journal of Cardiothoracic and Vascular Anesthesia, 10.1016/1053-0770(93)90315-C, 7:5, (560-565), Online publication date: 1-Oct-1993. Berner M, Jaccard C, Oberhansli I, Rouge J and Friedli B (1990) Hemodynamic effects of amrinone in children after cardiac surgery, Intensive Care Medicine, 10.1007/BF01699851, 16:2, (85-88), Online publication date: 1-Feb-1990. Berner M, Jaccard C, Oberhansli I, Rouge J and Friedli B (1990) Hemodynamic effects of amrinone in children after cardiac surgery, Intensive Care Medicine, 10.1007/BF02575299, 16:2, (85-88), Online publication date: 1-Nov-1990. Bakewell S, Coates W, Comer M, Reeves M and Warrington B (1990) Inotropic, vasodilator and low Km, cAMP-selective, cGMP-inhibited phosphodiesterase (PDE III) inhibitory activities of 4a-methyl-4,4a-dihydro-5H-indeno[1,2-c]pyridazin-3(2H)-ones and 4a-methyl-4,4a,5,6-tetrahydrobenzo[h]cinnolin-3(2H)-ones, European Journal of Medicinal Chemistry, 10.1016/0223-5234(90)90196-A, 25:9, (765-774), Online publication date: 1-Nov-1990. Weishaar R, Kobylarz-Singer D and Klinkefus B (1989) New mechanisms for positive inotropic agents: Focus on the discovery and development of imazodan, Cardiovascular Drugs and Therapy, 10.1007/BF01881527, 3:1, (29-42), Online publication date: 1-Jan-1989. Pang D (1988) Cyclic AMP and cyclic GMP phosphodiesterases: Target for drug development, Drug Development Research, 10.1002/ddr.430120203, 12:2, (85-92), . Weishaar R, Kobylarz-Singer D, Quade M and Kaplan H (1988) Role of cyclic AMP in regulating cardiac muscle contractility: Novel pharmacological approaches to modulating cyclic AMP degradation by phosphodiesterase, Drug Development Research, 10.1002/ddr.430120206, 12:2, (119-129), . Kariya T and Dage R (1988) Tissue distribution and selective inhibition of subtypes of high affinity cAMP phosphodiesterase, Biochemical Pharmacology, 10.1016/0006-2952(88)90637-5, 37:17, (3267-3270), Online publication date: 1-Sep-1988. Sørensen E and Nielsen-Kudsk F (1986) Myocardial pharmacodynamics of dopamine, dobutamine, amrinone and isoprenaline compared in the isolated rabbit heart, European Journal of Pharmacology, 10.1016/0014-2999(86)90123-8, 124:1-2, (51-57), Online publication date: 1-May-1986. Massie B, Bourassa M, DiBianco R, Hess M, Konstam M, Likoff M and Packer M (1985) Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial., Circulation, 71:5, (963-971), Online publication date: 1-May-1985. Carpenedo F, Floreani M and Cargnelli G (1984) Competitive inhibition of phosphodiesterase activity by amrinone: Its implication in the cardiac effect of the drug, Pharmacological Research Communications, 10.1016/S0031-6989(84)80061-2, 16:10, (969-977), Online publication date: 1-Oct-1984. Binah O, Legato M, Danilo P and Rosen M (1983) Developmental changes in the cardiac effects of amrinone in the dog., Circulation Research, 52:6, (747-752), Online publication date: 1-Jun-1983. Chen Z, Lee K, Chen L, Wang L, Niu H, Cheng J and Bolego C (2013) Cardiac Peroxisome Proliferator-Activated Receptor δ (PPARδ) as a New Target for Increased Contractility without Altering Heart Rate, PLoS ONE, 10.1371/journal.pone.0064229, 8:5, (e64229) June 1, 1980Vol 46, Issue 6 Advertisement Article InformationMetrics Copyright © 1980 by American Heart Associationhttps://doi.org/10.1161/01.RES.46.6.887 Originally publishedJune 1, 1980 PDF download Advertisement